Spots Global Cancer Trial Database for breast cancer, metastatic
Every month we try and update this database with for breast cancer, metastatic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer | NCT00288249 | Breast Neoplasm... Breast Cancer, ... | Sagopilone (BAY... Sagopilone (BAY... Sagopilone (BAY... Sagopilone (BAY... | 18 Years - | Bayer | |
| Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System | NCT03427450 | Healthy Volunte... Breast Cancer, ... | Blood draw | 22 Years - | Angle plc | |
| Cancer Experience Registry (CER) for Cancer Patients and Caregivers | NCT02333604 | Neoplasms Cancer Caregiver | 18 Years - | Cancer Support Community, Research and Training Institute, Philadelphia | ||
| Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer | NCT01045304 | Breast Cancer, ... | Iniparib Gemcitabine Carboplatin | 18 Years - | Sanofi | |
| Cancer Experience Registry (CER) for Cancer Patients and Caregivers | NCT02333604 | Neoplasms Cancer Caregiver | 18 Years - | Cancer Support Community, Research and Training Institute, Philadelphia | ||
| Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer | NCT00288249 | Breast Neoplasm... Breast Cancer, ... | Sagopilone (BAY... Sagopilone (BAY... Sagopilone (BAY... Sagopilone (BAY... | 18 Years - | Bayer | |
| Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer | NCT01045304 | Breast Cancer, ... | Iniparib Gemcitabine Carboplatin | 18 Years - | Sanofi | |
| Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer | NCT01045304 | Breast Cancer, ... | Iniparib Gemcitabine Carboplatin | 18 Years - | Sanofi | |
| Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer | NCT01067989 | Chemotherapy Breast Cancer, ... | Cyclophosphamid... | 18 Years - 80 Years | HaEmek Medical Center, Israel | |
| Cancer Experience Registry (CER) for Cancer Patients and Caregivers | NCT02333604 | Neoplasms Cancer Caregiver | 18 Years - | Cancer Support Community, Research and Training Institute, Philadelphia | ||
| Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients | NCT00044525 | Breast Neoplasm... Breast Cancer, ... | BAY59-8862 (Cyt... | 18 Years - | Bayer | |
| Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System | NCT03427450 | Healthy Volunte... Breast Cancer, ... | Blood draw | 22 Years - | Angle plc | |
| Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients | NCT00044525 | Breast Neoplasm... Breast Cancer, ... | BAY59-8862 (Cyt... | 18 Years - | Bayer | |
| Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer | NCT01067989 | Chemotherapy Breast Cancer, ... | Cyclophosphamid... | 18 Years - 80 Years | HaEmek Medical Center, Israel | |
| Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer | NCT01045304 | Breast Cancer, ... | Iniparib Gemcitabine Carboplatin | 18 Years - | Sanofi | |
| Cancer Experience Registry (CER) for Cancer Patients and Caregivers | NCT02333604 | Neoplasms Cancer Caregiver | 18 Years - | Cancer Support Community, Research and Training Institute, Philadelphia |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
